KNIGHT CAPITOL CONSULTANTS for INDIVIOR, INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Funding for opioid overuse treatment activities for FY 2020 (H.R. 2740/no Senate bill number yet)
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICIA KNIGHT | Chief of Staff, Senator Orrin G. Hatch |
Medicare/Medicaid MMM
Omnibus legislation affecting prescription drug pricing (Senate HELP "Lower Healthcare Costs Act (S. 1895) and Finance bill (in development); H.R. 965, the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019; and S. 102/H.R. 465, Prescription Drug Pricing Relief Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICIA KNIGHT | Chief of Staff, Senator Orrin G. Hatch (1999-2007) |
Alcohol and Drug Abuse ALC
Implementation of the Support for Patients and Communities Act (P.L. 115-271); funding levels and distribution of funding for treatment of opioid overuse disorder (OUD) (H.R. 2740); promote awareness of medication assisted treatmennt/treatment of OUD with long-acting injectable products.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICIA KNIGHT | Chief of Staff, Senator Orrin G. Hatch |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.